Myeloperoxidase polymorphism and cognitive decline in older adults in the health, aging, and body composition study

Sandra K. Pope, Stephen B. Kritchevsky, Christine Ambrosone, Kristine Yaffe, Frances Tylavsky, Eleanor M. Simonsick, Caterina Rosano, Scott Stewart, Tamara Harris

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Myeloperoxidase, an antimicrobial enzyme, produces oxidative free radicals. Rarely found in normal brain tissue, myeloperoxidase has been detected in microglia associated with Alzheimer's disease plaques. The authors examined a G-463A polymorphism in the promoter region of the myeloperoxidase gene (MPO) to determine the relation of MPO variants to cognitive decline over 4 years in a cohort of adults, aged 70-79 years at baseline (1997-1998), recruited from Memphis, Tennessee, and Pittsburgh, Pennsylvania, into the Health, Aging, and Body Composition Study. In this sample, 8% of the participants had the AA, 36.9% the AG, and 55.2% the GG genotype of MPO. The frequency of AA and AG genotypes was higher in Blacks than Whites (11.2% vs. 5.9%, and 44.1% vs. 32.9%, respectively). Multivariate logistic regression analyses showed that, for participants with the MPO AA genotype, cognitive decline was 1.58 (95% confidence interval: 1.07, 2.35) times more likely than for participants with the AG genotype and 1.96 (95% confidence interval: 1.33, 2.88) times more likely than for those with the GG genotype. Interactions between MPO and race, sex, or the apolipoprotein gene were not significant. In this sample, MPO AA, associated with decreased production of myeloperoxidase, was found to be a risk factor for cognitive decline.

Original languageEnglish (US)
Pages (from-to)1084-1090
Number of pages7
JournalAmerican Journal of Epidemiology
Volume163
Issue number12
DOIs
StatePublished - Jun 1 2006

Fingerprint

Body Composition
Peroxidase
Health
Genotype
Genes
Confidence Intervals
Cognitive Dysfunction
Apolipoproteins
Microglia
Genetic Promoter Regions
Free Radicals
Alzheimer Disease
Logistic Models
Regression Analysis
Brain
Enzymes

All Science Journal Classification (ASJC) codes

  • Epidemiology

Cite this

Myeloperoxidase polymorphism and cognitive decline in older adults in the health, aging, and body composition study. / Pope, Sandra K.; Kritchevsky, Stephen B.; Ambrosone, Christine; Yaffe, Kristine; Tylavsky, Frances; Simonsick, Eleanor M.; Rosano, Caterina; Stewart, Scott; Harris, Tamara.

In: American Journal of Epidemiology, Vol. 163, No. 12, 01.06.2006, p. 1084-1090.

Research output: Contribution to journalArticle

Pope, SK, Kritchevsky, SB, Ambrosone, C, Yaffe, K, Tylavsky, F, Simonsick, EM, Rosano, C, Stewart, S & Harris, T 2006, 'Myeloperoxidase polymorphism and cognitive decline in older adults in the health, aging, and body composition study', American Journal of Epidemiology, vol. 163, no. 12, pp. 1084-1090. https://doi.org/10.1093/aje/kwj146
Pope, Sandra K. ; Kritchevsky, Stephen B. ; Ambrosone, Christine ; Yaffe, Kristine ; Tylavsky, Frances ; Simonsick, Eleanor M. ; Rosano, Caterina ; Stewart, Scott ; Harris, Tamara. / Myeloperoxidase polymorphism and cognitive decline in older adults in the health, aging, and body composition study. In: American Journal of Epidemiology. 2006 ; Vol. 163, No. 12. pp. 1084-1090.
@article{e00f4855c3c84b46a5f05858ce0d4229,
title = "Myeloperoxidase polymorphism and cognitive decline in older adults in the health, aging, and body composition study",
abstract = "Myeloperoxidase, an antimicrobial enzyme, produces oxidative free radicals. Rarely found in normal brain tissue, myeloperoxidase has been detected in microglia associated with Alzheimer's disease plaques. The authors examined a G-463A polymorphism in the promoter region of the myeloperoxidase gene (MPO) to determine the relation of MPO variants to cognitive decline over 4 years in a cohort of adults, aged 70-79 years at baseline (1997-1998), recruited from Memphis, Tennessee, and Pittsburgh, Pennsylvania, into the Health, Aging, and Body Composition Study. In this sample, 8{\%} of the participants had the AA, 36.9{\%} the AG, and 55.2{\%} the GG genotype of MPO. The frequency of AA and AG genotypes was higher in Blacks than Whites (11.2{\%} vs. 5.9{\%}, and 44.1{\%} vs. 32.9{\%}, respectively). Multivariate logistic regression analyses showed that, for participants with the MPO AA genotype, cognitive decline was 1.58 (95{\%} confidence interval: 1.07, 2.35) times more likely than for participants with the AG genotype and 1.96 (95{\%} confidence interval: 1.33, 2.88) times more likely than for those with the GG genotype. Interactions between MPO and race, sex, or the apolipoprotein gene were not significant. In this sample, MPO AA, associated with decreased production of myeloperoxidase, was found to be a risk factor for cognitive decline.",
author = "Pope, {Sandra K.} and Kritchevsky, {Stephen B.} and Christine Ambrosone and Kristine Yaffe and Frances Tylavsky and Simonsick, {Eleanor M.} and Caterina Rosano and Scott Stewart and Tamara Harris",
year = "2006",
month = "6",
day = "1",
doi = "10.1093/aje/kwj146",
language = "English (US)",
volume = "163",
pages = "1084--1090",
journal = "American Journal of Epidemiology",
issn = "0002-9262",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Myeloperoxidase polymorphism and cognitive decline in older adults in the health, aging, and body composition study

AU - Pope, Sandra K.

AU - Kritchevsky, Stephen B.

AU - Ambrosone, Christine

AU - Yaffe, Kristine

AU - Tylavsky, Frances

AU - Simonsick, Eleanor M.

AU - Rosano, Caterina

AU - Stewart, Scott

AU - Harris, Tamara

PY - 2006/6/1

Y1 - 2006/6/1

N2 - Myeloperoxidase, an antimicrobial enzyme, produces oxidative free radicals. Rarely found in normal brain tissue, myeloperoxidase has been detected in microglia associated with Alzheimer's disease plaques. The authors examined a G-463A polymorphism in the promoter region of the myeloperoxidase gene (MPO) to determine the relation of MPO variants to cognitive decline over 4 years in a cohort of adults, aged 70-79 years at baseline (1997-1998), recruited from Memphis, Tennessee, and Pittsburgh, Pennsylvania, into the Health, Aging, and Body Composition Study. In this sample, 8% of the participants had the AA, 36.9% the AG, and 55.2% the GG genotype of MPO. The frequency of AA and AG genotypes was higher in Blacks than Whites (11.2% vs. 5.9%, and 44.1% vs. 32.9%, respectively). Multivariate logistic regression analyses showed that, for participants with the MPO AA genotype, cognitive decline was 1.58 (95% confidence interval: 1.07, 2.35) times more likely than for participants with the AG genotype and 1.96 (95% confidence interval: 1.33, 2.88) times more likely than for those with the GG genotype. Interactions between MPO and race, sex, or the apolipoprotein gene were not significant. In this sample, MPO AA, associated with decreased production of myeloperoxidase, was found to be a risk factor for cognitive decline.

AB - Myeloperoxidase, an antimicrobial enzyme, produces oxidative free radicals. Rarely found in normal brain tissue, myeloperoxidase has been detected in microglia associated with Alzheimer's disease plaques. The authors examined a G-463A polymorphism in the promoter region of the myeloperoxidase gene (MPO) to determine the relation of MPO variants to cognitive decline over 4 years in a cohort of adults, aged 70-79 years at baseline (1997-1998), recruited from Memphis, Tennessee, and Pittsburgh, Pennsylvania, into the Health, Aging, and Body Composition Study. In this sample, 8% of the participants had the AA, 36.9% the AG, and 55.2% the GG genotype of MPO. The frequency of AA and AG genotypes was higher in Blacks than Whites (11.2% vs. 5.9%, and 44.1% vs. 32.9%, respectively). Multivariate logistic regression analyses showed that, for participants with the MPO AA genotype, cognitive decline was 1.58 (95% confidence interval: 1.07, 2.35) times more likely than for participants with the AG genotype and 1.96 (95% confidence interval: 1.33, 2.88) times more likely than for those with the GG genotype. Interactions between MPO and race, sex, or the apolipoprotein gene were not significant. In this sample, MPO AA, associated with decreased production of myeloperoxidase, was found to be a risk factor for cognitive decline.

UR - http://www.scopus.com/inward/record.url?scp=33745625361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745625361&partnerID=8YFLogxK

U2 - 10.1093/aje/kwj146

DO - 10.1093/aje/kwj146

M3 - Article

VL - 163

SP - 1084

EP - 1090

JO - American Journal of Epidemiology

JF - American Journal of Epidemiology

SN - 0002-9262

IS - 12

ER -